Lessons learnt in the management of Wegener's granulomatosis: long-term follow-up of 60 patients

被引:0
|
作者
Sproson, E. L.
Jones, N. S. [1 ]
Al-Deiri, M.
Lanyon, P.
机构
[1] Univ Nottingham Hosp, Queens Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Nottingham NG7 2UH, England
[2] Univ Nottingham Hosp, Queens Med Ctr, Dept Rheumatol, Nottingham NG7 2UH, England
关键词
Wegener's granulomatosis; cANCA; ESR; CRP; presenting features; diagnosis; adverse affects of treatment; mortality rate;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To assess all patients with Wegener's Granulomatosis treated in Nottingham, with particular focus on relapse rate and the useful predictors of relapse. We evaluated how well the findings of nasal examination correlated with disease relapse compared to other parameters such as c-ANCA, ESR and CRP. Presenting features, diagnosis, adverse effects of treatment and mortality rate, were also studied. Design: Retrospective examination of 60 patient notes, diagnosed and treated for Wegener's granulomatosis at Queen's Medical Centre, Nottingham. The mean follow up period was 8.7 years. Relapse was de defined as per the European Vasculitis Study criteria. Results: cANCA is a useful test at presentation for diagnosis but a negative result does not rule out the disease. Those presenting with ENT symptoms alone may have less raised inflammatory markers but similar cANCA titres as patients with multi-system disease. However, at relapse, patients with ENT disease alone have similar levels of inflammatory markers as those with multi-system relapse. Nasal examination was useful at monitoring the presence of disease activity where the nasal lining is affected. Conclusions: Signs of intranasal disease in the form of granular tissue, erythema and bleeding to light touch and crusting over granulation tissue are good predictors of disease activity. A raised cANCA, ESR or CRP provide supporting information about disease activity but if they are negative this does not exclude active disease. cANCA levels were as elevated at relapse in patients who had isolated nasal symptoms and signs as in those with evidence of systemic disease. Low relapse rates were found possibly due to prompt and rigorous initial immunosuppression even in limited disease. This seemed to lead to less progression of patients to multi-system disease and hence a low mortality rate of 5%.
引用
收藏
页码:63 / 67
页数:5
相关论文
共 50 条
  • [1] Patients with Wegener's granulomatosis: a long-term follow-up study
    de Leeuw, K.
    van der Graaf, A. M.
    Bijzet, J.
    Stegeman, C. A.
    Smit, A. J.
    Kallenberg, C. G.
    Bijl, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (01) : S18 - S23
  • [2] Rituximab and leflunomide for Wegener's granulomatosis: a long-term follow-up
    Henes, J. C.
    Kanz, L.
    Koetter, I.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2011, 31 (03) : 425 - 426
  • [3] Rituximab and leflunomide for Wegener’s granulomatosis: a long-term follow-up
    J. C. Henes
    L. Kanz
    I. Koetter
    [J]. Rheumatology International, 2011, 31 : 425 - 426
  • [4] Wegener's granulomatosis: Long-term follow-up of patients treated with pulse cyclophosphamide
    Koldingsnes, W
    Gran, JT
    Omdal, R
    Husby, G
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (06): : 659 - 664
  • [5] Long-term follow-up of repair of external nasal deformities in patients with Wegener's granulomatosis
    Congdon, D
    Sherris, DA
    Specks, U
    McDonald, T
    [J]. LARYNGOSCOPE, 2002, 112 (04): : 731 - 737
  • [6] Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?
    Holle, Julia U.
    Gross, Wolfgang L.
    Holl-Ulrich, Konstanze
    Ambrosch, Petra
    Noelle, Bernhard
    Both, Marcus
    Csernok, Elena
    Moosig, Frank
    Schinke, Susanne
    Reinhold-Keller, Eva
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (11) : 1934 - 1939
  • [7] Granulomatous polyangitis (Wegener granulomatosis): Clinical findings and results of long-term follow-up
    Sen, Nazan
    Aydin Tufan, Muge
    Yildiz, Reyhan
    Ersozlu Bozkirli, Emine Duygu
    Yucel, Eftal
    [J]. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2016, 64 (03): : 223 - 229
  • [8] Pulmonary function and high resolution CT findings after long-term follow-up of patients with Wegener's granulomatosis.
    Koldingsnes, W
    Jacobsen, E
    Sildnes, T
    Nossent, H
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S186 - S186
  • [9] Rituximab and leflunomide for Wegener's granulomatosis: a long time follow-up
    Henes, Joerg
    Horger, Marius
    Kanz, Lothar
    Koetter, Ina
    [J]. APMIS, 2009, 117 : 79 - 79
  • [10] LONG-TERM FOLLOW-UP OF WEGENER GRANULOMATOSIS PATIENTS TREATED WITH CYTO-TOXIC AGENTS PLUS STEROIDS
    KORETZ, SH
    FEIGENBAUM, PA
    RAITT, JW
    [J]. ARTHRITIS AND RHEUMATISM, 1980, 23 (06): : 706 - 706